ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2015
Learning From Leaders: Life-span Trends in Olympians and Supercentenarians.
Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Why Gilgamesh failed: the mechanistic basis of the limits to human lifespan.Nature aging · 2022Review
- Limits to lifespan growth.Frontiers in public health · 2022Article
- Are We Approaching a Biological Limit to Human Longevity?The journals of gerontology. Series A, Biological sciences and medical sciences · 2020Article
- Do Centenarians Die Healthier than Younger Elders? A Comparative Epidemiological Study in Spain.Journal of clinical medicine · 2020Article
- Mortality of Japanese Olympic athletes: 1952-2017 cohort study.BMJ open sport & exercise medicine · 2019Article
- A Medal in the Olympics Runs in the Family: A Cohort Study of Performance Heritability in the Games History.Frontiers in physiology · 2018Article
- Mortality and causes of death among Croatian male Olympic medalists.Croatian medical journal · 2017Article
- Dong et al. reply.Nature · 2017Article
- Debate on human aging and lifespan.BioImpacts : BI · 2017Article
- Are We Reaching the Limits ofFrontiers in physiology · 2017Review
- Covid-19 Mortality: A Matter of Vulnerability Among Nations Facing Limited Margins of Adaptation.Frontiers in public healthArticle
- Probabilistic forecasting of maximum human lifespan by 2100 using Bayesian population projections.Demographic researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Life-span trends progression has worldwide practical implications as it may affect the sustainability of modern societies. We aimed to describe the secular life-span trends of populations with a propensity to live longer-Olympians and supercentenarians-under two hypotheses: an ongoing life-span extension versus a biologic "probabilistic barrier" limiting further progression. In a study of life-span densities (total number of life durations per birth date), we analyzed 19,012 Olympians and 1,205 supercentenarians deceased between 1900 and 2013. Among most Olympians, we observed a trend toward increased life duration. This trend, however, decelerates at advanced ages leveling off with the upper values with a perennial gap between Olympians and supercentenarians during the whole observation period. Similar tendencies are observed among supercentenarians, and over the last years, a plateau attests to a stable longevity pattern among the longest-lived humans. The common trends between Olympians and supercentenarians indicate similar mortality pressures over both populations that increase with age, scenario better explained by a biologic "barrier" forecast.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.